![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1715166
ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¿¹Ãø(-2031³â) : Áö¿ªº° ºÐ¼®(Á¦Ç°º°, ÀûÀÀÁõº°, Ä«Å×°í¸®º°, ½Ã½ºÅÛ À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°)North America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product, Indication, Category, System Type, and End User |
ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº 2023³â¿¡ 10¾ï 3,579¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â¿¡´Â 15¾ï 664¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2023³âºÎÅÍ 2031³â±îÁö CAGR 4.8%·Î ÃßÁ¤µË´Ï´Ù.
¿ä½Ç±Ý ±ÞÁõÀ¸·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå Ȱ¼ºÈ
¿ä½Ç±Ý(UI)Àº ¼¼°èÀÇ »ó´çÇÑ Àα¸¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¡Àå ÀϹÝÀûÀÎ ¹®Á¦ÀÔ´Ï´Ù. ºñ¸¸ À¯º´·ü Áõ°¡, ³ë³â Àα¸ Áõ°¡, Àü¸³¼±¾Ï, ´ç´¢º´, ½ÅÀå Áúȯ, ´Ù¹ß¼º °æÈÁõ µîÀÇ ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡´Â UIÀÇ ÁÖ¿ä À§Çè ÀÎÀÚ Áß ÇϳªÀÔ´Ï´Ù.
UI°¡ ÀÇ·á½Ã½ºÅÛ¿¡ ÁÖ´Â °æÁ¦Àû ºÎ´ãÀº ¼¼°è °í·ÉÀÚ Àα¸°¡ ±ÞÁõÇÔ¿¡ µû¶ó Ä¿Áö°í ÀÖ½À´Ï´Ù. Mayo Clinic Health SystemÀÌ 2023³â¿¡ ¹ßÇ¥ÇÑ ±â»ç¿¡ ÀÇÇϸé, ¼Òº¯ ´©¼³Àº °í·ÉÀÚ Àα¸ÀÇ 50% °¡±îÀ̰¡ ÀÌȯÇÏ´Â ÀϹÝÀûÀÎ Áõ»óÀÔ´Ï´Ù. ÀÌ Áõ»óÀÇ À¯º´·üÀº ¿¬·É°ú ÇÔ²² Áõ°¡Çϸç, ¾î´À ¿¬·ÉÃþÀÇ ³²¼ºº¸´Ùµµ ¿©¼º¿¡°Ô ¸¹¾Æ 65¼¼ ÀÌ»óÀÇ ¿©¼ºÀÇ ÃÖ´ë 75%°¡ ¼Òº¯ ´©¼³¿¡ ½Ã´Þ¸®°í ÀÖ½À´Ï´Ù. ¹æ±¤ÀÌ ºñ¿öÁø ÈÄ, Ä«Å×Å͸¦ ºüÁ® ³ª°¡¸é ¾Æ¹«·± ÁöÀåµµ °ÆÁ¤ÇÏÁö ¾Ê°í ÀÏ»ó »ýȰÀ» °è¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ UI À¯º´·üÀÇ »ó½ÂÀÌ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå °³¿ä
Àα¸¹®Á¦¿¬±¸¼Ò¿¡ µû¸£¸é 65¼¼ ÀÌ»óÀÇ °í·ÉÀÚ ¼ö´Â 2023³â¿¡´Â 5,800¸¸¸íÀ¸·Î, 2050³â¿¡´Â 8,200¸¸¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ Áúº´ °ü¸® ¿¹¹æ ¼¾ÅÍ¿¡ µû¸£¸é, ¿ä½Ç±ÝÀº ´ç´¢º´À̳ª ³úÁ¹Áß µîÀÇ ¸¸¼º Áúȯ, ÀÎÁö Àå¾Ö, ÀÌȯ Àå¾Ö µî ´Ù¾çÇÑ ¿äÀÎÀ¸·ÎºÎÅÍ, 65¼¼ ÀÌ»óÀÇ °í·ÉÀÚÀÇ ÁÖ¿ä Áõ»ó°ú ¶ÇÇÑ ¹Ì±¹ ô¼ö ¼Õ»ó Åë°è ¼¾ÅÍ¿¡ µû¸£¸é ¸Å³â 17,500 ¸íÀÌ SCI¸¦ ¾Î°í ÀÖÀ¸¸ç ƯÈ÷ ³ë³â Àα¸°¡ ¸¹´Ù°í ÃßÁ¤µË´Ï´Ù. ÅëÁ¦¸¦ À§ÇØ ¿äµµ Ä«Å×ÅÍÀÇ µµ¿òÀÌ ÇÊ¿äÇÏ¸ç ¿äµµ Ä«Å×ÅͰ¡ ÁÖ·Î »ç¿ëµË´Ï´Ù.
ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¼öÀͰú 2031³â±îÁö ¿¹Ãø(±Ý¾× ±âÁØ)
ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¼¼ºÐÈ
ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº Á¦Ç° À¯Çü, ÀûÀÀÁõ, Ä«Å×°í¸®, ½Ã½ºÅÛ À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡·Î ºÐ·ùµË´Ï´Ù.
Á¦Ç°º°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ¿Í ºñÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ·Î ±¸ºÐµË´Ï´Ù.
ÀûÀÀÁõº°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ¿ä½Ç±Ý, ÀÏ¹Ý ¼ö¼ú, ô¼ö ¼Õ»ó, ÆÄŲ½¼º´(pd), ´Ù¹ß¼º °æÈÁõ µîÀ¸·Î ±¸ºÐµË´Ï´Ù.
¹üÁÖº°·Î º¸¸é ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ¿©¼º¿ë Ä«Å×ÅÍ, ³²¼º¿ë Ä«Å×ÅÍ, ¾Æµ¿¿ë Ä«Å×ÅÍ·Î ºÐ·ùµË´Ï´Ù.
½Ã½ºÅÛ À¯Çüº°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº Æó¼âÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛ°ú °³¹æÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛÀ¸·Î 2ºÐȵ˴ϴÙ.
ÃÖÁ¾ »ç¿ëÀÚº°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅÃÄ¡·á µîÀ¸·Î ±¸ºÐµË´Ï´Ù.
±¹°¡º°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù.
Advin Health Care Pvt Ltd, B Braun SE, Boston Scientific Corp, Cardinal Health Inc, Coloplast Corp, Convatec Group Plc, Hollister Inc, Medical Technologies of Georgia, Inc, Teleflex Inc, Wellspect HealthCare µîÀÌ ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡¼ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.
The North America intermittent catheters market was valued at US$ 1,035.79 million in 2023 and is expected to reach US$ 1,506.64 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031.
Surging Prevalence of Urinary Incontinence Fuels North America Intermittent Catheters Market
Urinary incontinence (UI) is the most common problem affecting a substantial global population. It results in occasional or minor leaking or uncontrolled chronic urination, in worse cases. The growing prevalence of obesity; the increasing geriatric population; and the rising incidence of chronic diseases such as prostate cancer, diabetes, kidney diseases, and multiple sclerosis are among the prime risk factors for UI. Medical conditions such as spinal cord injuries, cerebral palsy, prostate enlargement, multiple sclerosis, and cancer, among others, may lead to UI in the geriatric population.
The economic burden of UI on healthcare systems grows with the surging elderly population across the world. According to the World Health Organization (WHO), the total population aged 60 and above was 1 billion in 2020, and it is expected to reach 1.4 billion by 2031. According to an article published by Mayo Clinic Health System in 2023, the uncontrolled leakage of urine is a common symptom that affects almost 50% of the elderly population. The prevalence of this condition increases with age, and it affects more women than men of any age; up to 75% of women over 65 suffer from urine leakage. Intermittent urinary catheters are inserted into the bladder of individuals through the urethra several times a day to carry urine out of their body; it is kept in the bladder for just long enough to drain it before removing it. By catheterizing themselves, people can gain better control over their bladder. Once the catheter is removed after the bladder is emptied, people can continue their daily activities without any hindrances and awkwardness. Thus, the rising prevalence of UI is driving the growth of the intermittent catheters market.
North America Intermittent Catheters Market Overview
According to the Population Reference Bureau, the number of people aged 65 and above was 58 million in 2023 and it is estimated to increase to 82 million by 2050. This aging population is more susceptible to spinal cord injury (SCI), urinary incontinence, and benign prostate hyperplasia. For instance, according to the Centers for Disease Control and Prevention, urinary incontinence is a major symptom among people aged 65 or above due to various factors, including chronic conditions such as diabetes and stroke, cognitive impairment, and morbidity impairment. Moreover, according to the National Spinal Cord Injury Statistical Center, it was estimated that each year, 17,500 people were suffering from SCI in the US, especially among the geriatric population. Patients affected by SCI majorly need the help of urinary catheterization to control neurogenic bladder dysfunction, where urinary catheters are mainly used. Thus, the growing use of urinary catheters is expected to fuel the growth of the urinary catheters market in the country.
North America Intermittent Catheters Market Revenue and Forecast to 2031 (US$ Million)
North America Intermittent Catheters Market Segmentation
The North America intermittent catheters market is categorized into product, indication, category, system type, end user, and country.
By product, the North America intermittent catheters market is segmented into coated intermittent catheters and uncoated intermittent catheters. The coated intermittent catheters segment held a larger share of the North America intermittent catheters market share in 2023.
In terms of indication, the North America intermittent catheters market is segmented into urinary incontinence, general surgeries, spinal cord injuries, Parkinson's Disease (pd), multiple sclerosis, and others. The urinary incontinence segment held the largest share of the North America intermittent catheters market share in 2023.
Based on category, the North America intermittent catheters market is female length catheters, male length catheters, and kid length catheters. The female length catheters segment held the largest share of the North America intermittent catheters market share in 2023.
By system type, the North America intermittent catheters market is bifurcated into closed intermittent catheters systems and open intermittent catheters systems. The closed intermittent catheters systems segment held a larger share of the North America intermittent catheters market share in 2023.
In terms of end user, the North America intermittent catheters market is segmented into hospitals, ambulatory surgical centers, home care settings, and others. The hospitals segment held the largest share of the North America intermittent catheters market share in 2023.
Based on country, the North America intermittent catheters market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America intermittent catheters market in 2023.
Advin Health Care Pvt Ltd; B Braun SE; Boston Scientific Corp; Cardinal Health Inc; Coloplast Corp; Convatec Group Plc; Hollister Inc; Medical Technologies of Georgia, Inc.; Teleflex Inc; and Wellspect HealthCare are some of the leading companies operating in the North America intermittent catheters market.